PRESS RELEASE published on 03/12/2024 at 06:30, 2 years 1 month ago Affluent Medical annonce le succès de la première implantation chez l’homme de son sphincter artificiel Artus pour le traitement de l’incontinence urinaire d’effort. Affluent Medical annonce le succès de la première implantation chez l'homme de son sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort Affluent Medical Dispositif Médical Incontinence Urinaire Artus Implantation
PRESS RELEASE published on 03/12/2024 at 06:30, 2 years 1 month ago Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence. Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatment of stress urinary incontinence in Prague, Czech Republic. The innovative medical device offers hope for the estimated 400 million patients affected worldwide Medical Device Affluent Medical Urinary Incontinence Artus First-in-human Implantation
BRIEF published on 02/29/2024 at 17:50, 2 years 2 months ago Affluent Medical annonce des résultats positifs pour la valve Epygon Affluent Medical Prothèses Médicales Valve Epygon Insuffisance Mitrale Biomimétique
BRIEF published on 02/29/2024 at 17:50, 2 years 2 months ago Affluent Medical Announces Positive Results for Epygon Valve Affluent Medical Epygon Valve Mitral Regurgitation Biomimetics Medical Prostheses
BRIEF published on 02/29/2024 at 17:50, 2 years 2 months ago Affluent Medical Reports Promising Epygon Valve Performance and Recognition Affluent Medical Cardiology Epygon Valve Mitral Regurgitation Minimally Invasive Surgery
BRIEF published on 02/29/2024 at 17:50, 2 years 2 months ago Des rapports médicaux riches promettent des performances et une reconnaissance de la valve Epygon Cardiologie Insuffisance Mitrale Médical Aisé Vanne Épygone La Chirurgie Minimalement Invasive
PRESS RELEASE published on 02/29/2024 at 17:45, 2 years 2 months ago Affluent Medical : Performance exceptionnelle de la valve Epygon à un an et reconnaissance croissante du concept de valve mitrale biomimétique. Affluent Medical présente les résultats exceptionnels de la valve mitrale Epygon à un an et la reconnaissance croissante de son concept biomimétique par la communauté médicale Affluent Medical MedTech Biomimétique Epygon Valve Mitrale
PRESS RELEASE published on 02/29/2024 at 17:45, 2 years 2 months ago Affluent Medical : Excellent valve performance at 1 year follow up and rising recognition of Epygon biomimetic mitral valve. Affluent Medical reports excellent valve performance and increasing recognition of Epygon biomimetic mitral valve, as published in a peer-reviewed journal. The innovative device aims to enhance cardiac performance and patient outcomes Affluent Medical Epygon Mitral Valve Cardiac Performance Biomimetic
PRESS RELEASE published on 02/15/2024 at 17:40, 2 years 2 months ago Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.24. Affluent Medical communique le nombre d'actions et de droits de vote au 31/01/24 conforme aux réglementations. La société développe des implants innovants pour le traitement des maladies cardiaques et de l'incontinence urinaire Droits De Vote Actions Affluent Medical MedTech Maladies Cardiaques
PRESS RELEASE published on 01/29/2024 at 18:15, 2 years 3 months ago Affluent Medical closes €3.5 million bridge via capital increase from key shareholders. Affluent Medical closes €3.5 million bridge via capital increase from key shareholders. The transaction enables the company to continue exploring options for securing long-term financing and executing critical milestones. The bridge financing extends financial runway until May 2024 without impacting operational activities Bridge Financing Capital Increase Affluent Medical Long-term Financing Operational Activities
Published on 05/09/2026 at 01:30, 2 days ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 1 hour ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 9 hours 37 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 11 hours 42 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 13 hours 57 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 6 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 5 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 6 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 6 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 6 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 6 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 6 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL